SEC Form 4 · accession 0001571049-16-020777
PHIBRO ANIMAL HEALTH CORP · PAHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Larry Lee Miller
Officer — Chief Operating Officer
Period of report
Dec 19, 2016
Accepted (ET)
Dec 21, 2016 · 9:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Dec 19, 2016 | M | 252 | $11.83 | A | 252 | D | |
| Class A Common Stock | Dec 19, 2016 | S | 252 | $30.00 | D | 0 | D | |
| Class A Common Stock | Dec 20, 2016 | M | 1,540 | $11.83 | A | 1,540 | D | |
| Class A Common StockF2 | Dec 20, 2016 | S | 1,540 | $30.04 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase Class A Common Stock | $11.83 | Dec 19, 2016 | M | 252 | D | Apr 29, 2013 | Feb 28, 2019 | Class A Common Stock | 252 | 366,602 | D |
| Option to purchase Class A Common Stock | $11.83 | Dec 20, 2016 | M | 1,540 | D | Apr 29, 2013 | Feb 28, 2019 | Class A Common Stock | 1,540 | 365,062 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.10, inclusive.